0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Gene Sequencers Market Research Report 2026
Published Date: 2026-03-14
|
Report Code: QYRE-Auto-8R17677
Home | Market Reports
Global Targeted Gene Sequencers Market Research Report 2024
BUY CHAPTERS

Global Targeted Gene Sequencers Market Research Report 2026

Code: QYRE-Auto-8R17677
Report
2026-03-14
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Targeted Gene Sequencers Market

The global Targeted Gene Sequencers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Targeted Gene Sequencers competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Targeted Gene Sequencers is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Targeted Gene Sequencers is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Targeted Gene Sequencers include Thermo Fisher Scientific, Illumina, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences, Roche, Mgi Tech, GeneMind, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Targeted Gene Sequencers market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Targeted Gene Sequencers. The Targeted Gene Sequencers market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Targeted Gene Sequencers market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Targeted Gene Sequencers manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Targeted Gene Sequencers Market Report

Report Metric Details
Report Name Targeted Gene Sequencers Market
Segment by Type
  • Single Carrier
  • Multi-Carrier
by Application
  • Scientific Research
  • Clinical Medicine
  • Agriculture
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Illumina, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences, Roche, Mgi Tech, GeneMind
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Targeted Gene Sequencers manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Targeted Gene Sequencers sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Targeted Gene Sequencers Market report?

Ans: The main players in the Targeted Gene Sequencers Market are Thermo Fisher Scientific, Illumina, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences, Roche, Mgi Tech, GeneMind

What are the Application segmentation covered in the Targeted Gene Sequencers Market report?

Ans: The Applications covered in the Targeted Gene Sequencers Market report are Scientific Research, Clinical Medicine, Agriculture, Others

What are the Type segmentation covered in the Targeted Gene Sequencers Market report?

Ans: The Types covered in the Targeted Gene Sequencers Market report are Single Carrier, Multi-Carrier

1 Targeted Gene Sequencers Market Overview
1.1 Product Definition
1.2 Targeted Gene Sequencers by Type
1.2.1 Global Targeted Gene Sequencers Market Value by Type: 2025 vs 2032
1.2.2 Single Carrier
1.2.3 Multi-Carrier
1.3 Targeted Gene Sequencers by Application
1.3.1 Global Targeted Gene Sequencers Market Value by Application: 2025 vs 2032
1.3.2 Scientific Research
1.3.3 Clinical Medicine
1.3.4 Agriculture
1.3.5 Others
1.4 Global Targeted Gene Sequencers Market Size Estimates and Forecasts
1.4.1 Global Targeted Gene Sequencers Revenue 2021–2032
1.4.2 Global Targeted Gene Sequencers Sales 2021–2032
1.4.3 Global Targeted Gene Sequencers Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Targeted Gene Sequencers Market Competition by Manufacturers
2.1 Global Targeted Gene Sequencers Sales Market Share by Manufacturers (2021–2026)
2.2 Global Targeted Gene Sequencers Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Targeted Gene Sequencers Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Targeted Gene Sequencers, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Targeted Gene Sequencers, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Targeted Gene Sequencers, Product Types and Applications
2.7 Global Key Manufacturers of Targeted Gene Sequencers, Date of Entry into the Industry
2.8 Global Targeted Gene Sequencers Market Competitive Situation and Trends
2.8.1 Global Targeted Gene Sequencers Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Targeted Gene Sequencers Players Market Share by Revenue
2.8.3 Global Targeted Gene Sequencers Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Targeted Gene Sequencers Market Scenario by Region
3.1 Global Targeted Gene Sequencers Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Targeted Gene Sequencers Sales by Region: 2021–2032
3.2.1 Global Targeted Gene Sequencers Sales by Region: 2021–2026
3.2.2 Global Targeted Gene Sequencers Sales by Region: 2027–2032
3.3 Global Targeted Gene Sequencers Revenue by Region: 2021–2032
3.3.1 Global Targeted Gene Sequencers Revenue by Region: 2021–2026
3.3.2 Global Targeted Gene Sequencers Revenue by Region: 2027–2032
3.4 North America Targeted Gene Sequencers Market Facts & Figures by Country
3.4.1 North America Targeted Gene Sequencers Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Targeted Gene Sequencers Sales by Country (2021–2032)
3.4.3 North America Targeted Gene Sequencers Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Targeted Gene Sequencers Market Facts & Figures by Country
3.5.1 Europe Targeted Gene Sequencers Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Targeted Gene Sequencers Sales by Country (2021–2032)
3.5.3 Europe Targeted Gene Sequencers Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Targeted Gene Sequencers Market Facts & Figures by Region
3.6.1 Asia Pacific Targeted Gene Sequencers Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Targeted Gene Sequencers Sales by Region (2021–2032)
3.6.3 Asia Pacific Targeted Gene Sequencers Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Targeted Gene Sequencers Market Facts & Figures by Country
3.7.1 Latin America Targeted Gene Sequencers Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Targeted Gene Sequencers Sales by Country (2021–2032)
3.7.3 Latin America Targeted Gene Sequencers Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Targeted Gene Sequencers Market Facts & Figures by Country
3.8.1 Middle East and Africa Targeted Gene Sequencers Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Targeted Gene Sequencers Sales by Country (2021–2032)
3.8.3 Middle East and Africa Targeted Gene Sequencers Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Targeted Gene Sequencers Sales by Type (2021–2032)
4.1.1 Global Targeted Gene Sequencers Sales by Type (2021–2026)
4.1.2 Global Targeted Gene Sequencers Sales by Type (2027–2032)
4.1.3 Global Targeted Gene Sequencers Sales Market Share by Type (2021–2032)
4.2 Global Targeted Gene Sequencers Revenue by Type (2021–2032)
4.2.1 Global Targeted Gene Sequencers Revenue by Type (2021–2026)
4.2.2 Global Targeted Gene Sequencers Revenue by Type (2027–2032)
4.2.3 Global Targeted Gene Sequencers Revenue Market Share by Type (2021–2032)
4.3 Global Targeted Gene Sequencers Price by Type (2021–2032)
5 Segment by Application
5.1 Global Targeted Gene Sequencers Sales by Application (2021–2032)
5.1.1 Global Targeted Gene Sequencers Sales by Application (2021–2026)
5.1.2 Global Targeted Gene Sequencers Sales by Application (2027–2032)
5.1.3 Global Targeted Gene Sequencers Sales Market Share by Application (2021–2032)
5.2 Global Targeted Gene Sequencers Revenue by Application (2021–2032)
5.2.1 Global Targeted Gene Sequencers Revenue by Application (2021–2026)
5.2.2 Global Targeted Gene Sequencers Revenue by Application (2027–2032)
5.2.3 Global Targeted Gene Sequencers Revenue Market Share by Application (2021–2032)
5.3 Global Targeted Gene Sequencers Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Targeted Gene Sequencers Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Targeted Gene Sequencers Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Illumina
6.2.1 Illumina Company Information
6.2.2 Illumina Description and Business Overview
6.2.3 Illumina Targeted Gene Sequencers Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Illumina Targeted Gene Sequencers Product Portfolio
6.2.5 Illumina Recent Developments/Updates
6.3 Pacific Biosciences
6.3.1 Pacific Biosciences Company Information
6.3.2 Pacific Biosciences Description and Business Overview
6.3.3 Pacific Biosciences Targeted Gene Sequencers Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pacific Biosciences Targeted Gene Sequencers Product Portfolio
6.3.5 Pacific Biosciences Recent Developments/Updates
6.4 Oxford Nanopore Technologies
6.4.1 Oxford Nanopore Technologies Company Information
6.4.2 Oxford Nanopore Technologies Description and Business Overview
6.4.3 Oxford Nanopore Technologies Targeted Gene Sequencers Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Oxford Nanopore Technologies Targeted Gene Sequencers Product Portfolio
6.4.5 Oxford Nanopore Technologies Recent Developments/Updates
6.5 Element Biosciences
6.5.1 Element Biosciences Company Information
6.5.2 Element Biosciences Description and Business Overview
6.5.3 Element Biosciences Targeted Gene Sequencers Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Element Biosciences Targeted Gene Sequencers Product Portfolio
6.5.5 Element Biosciences Recent Developments/Updates
6.6 Roche
6.6.1 Roche Company Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Targeted Gene Sequencers Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Roche Targeted Gene Sequencers Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Mgi Tech
6.7.1 Mgi Tech Company Information
6.7.2 Mgi Tech Description and Business Overview
6.7.3 Mgi Tech Targeted Gene Sequencers Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Mgi Tech Targeted Gene Sequencers Product Portfolio
6.7.5 Mgi Tech Recent Developments/Updates
6.8 GeneMind
6.8.1 GeneMind Company Information
6.8.2 GeneMind Description and Business Overview
6.8.3 GeneMind Targeted Gene Sequencers Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 GeneMind Targeted Gene Sequencers Product Portfolio
6.8.5 GeneMind Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Targeted Gene Sequencers Industry Chain Analysis
7.2 Targeted Gene Sequencers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Targeted Gene Sequencers Production Mode & Process Analysis
7.4 Targeted Gene Sequencers Sales and Marketing
7.4.1 Targeted Gene Sequencers Sales Channels
7.4.2 Targeted Gene Sequencers Distributors
7.5 Targeted Gene Sequencers Customer Analysis
8 Targeted Gene Sequencers Market Dynamics
8.1 Targeted Gene Sequencers Industry Trends
8.2 Targeted Gene Sequencers Market Drivers
8.3 Targeted Gene Sequencers Market Challenges
8.4 Targeted Gene Sequencers Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Targeted Gene Sequencers Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Targeted Gene Sequencers Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Targeted Gene Sequencers Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Targeted Gene Sequencers Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Targeted Gene Sequencers Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Targeted Gene Sequencers Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Targeted Gene Sequencers Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Targeted Gene Sequencers Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Targeted Gene Sequencers, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Targeted Gene Sequencers, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Targeted Gene Sequencers, Product Types and Applications
 Table 12. Global Key Manufacturers of Targeted Gene Sequencers, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Targeted Gene Sequencers Companies by Tier (Tier 1, Tier 2, Tier 3), based on Targeted Gene Sequencers Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Targeted Gene Sequencers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Targeted Gene Sequencers Sales by Region (Units), 2021–2026
 Table 18. Global Targeted Gene Sequencers Sales Market Share by Region (2021–2026)
 Table 19. Global Targeted Gene Sequencers Sales by Region (Units), 2027–2032
 Table 20. Global Targeted Gene Sequencers Sales Market Share by Region (2027–2032)
 Table 21. Global Targeted Gene Sequencers Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Targeted Gene Sequencers Revenue Market Share by Region (2021–2026)
 Table 23. Global Targeted Gene Sequencers Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Targeted Gene Sequencers Revenue Market Share by Region (2027–2032)
 Table 25. North America Targeted Gene Sequencers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Targeted Gene Sequencers Sales by Country (Units), 2021–2026
 Table 27. North America Targeted Gene Sequencers Sales by Country (Units), 2027–2032
 Table 28. North America Targeted Gene Sequencers Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Targeted Gene Sequencers Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Targeted Gene Sequencers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Targeted Gene Sequencers Sales by Country (Units), 2021–2026
 Table 32. Europe Targeted Gene Sequencers Sales by Country (Units), 2027–2032
 Table 33. Europe Targeted Gene Sequencers Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Targeted Gene Sequencers Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Targeted Gene Sequencers Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Targeted Gene Sequencers Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Targeted Gene Sequencers Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Targeted Gene Sequencers Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Targeted Gene Sequencers Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Targeted Gene Sequencers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Targeted Gene Sequencers Sales by Country (Units), 2021–2026
 Table 42. Latin America Targeted Gene Sequencers Sales by Country (Units), 2027–2032
 Table 43. Latin America Targeted Gene Sequencers Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Targeted Gene Sequencers Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Targeted Gene Sequencers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Targeted Gene Sequencers Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Targeted Gene Sequencers Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Targeted Gene Sequencers Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Targeted Gene Sequencers Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Targeted Gene Sequencers Sales (Units) by Type (2021–2026)
 Table 51. Global Targeted Gene Sequencers Sales (Units) by Type (2027–2032)
 Table 52. Global Targeted Gene Sequencers Sales Market Share by Type (2021–2026)
 Table 53. Global Targeted Gene Sequencers Sales Market Share by Type (2027–2032)
 Table 54. Global Targeted Gene Sequencers Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Targeted Gene Sequencers Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Targeted Gene Sequencers Revenue Market Share by Type (2021–2026)
 Table 57. Global Targeted Gene Sequencers Revenue Market Share by Type (2027–2032)
 Table 58. Global Targeted Gene Sequencers Price (K US$/Unit) by Type (2021–2026)
 Table 59. Global Targeted Gene Sequencers Price (K US$/Unit) by Type (2027–2032)
 Table 60. Global Targeted Gene Sequencers Sales (Units) by Application (2021–2026)
 Table 61. Global Targeted Gene Sequencers Sales (Units) by Application (2027–2032)
 Table 62. Global Targeted Gene Sequencers Sales Market Share by Application (2021–2026)
 Table 63. Global Targeted Gene Sequencers Sales Market Share by Application (2027–2032)
 Table 64. Global Targeted Gene Sequencers Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Targeted Gene Sequencers Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Targeted Gene Sequencers Revenue Market Share by Application (2021–2026)
 Table 67. Global Targeted Gene Sequencers Revenue Market Share by Application (2027–2032)
 Table 68. Global Targeted Gene Sequencers Price (K US$/Unit) by Application (2021–2026)
 Table 69. Global Targeted Gene Sequencers Price (K US$/Unit) by Application (2027–2032)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific Targeted Gene Sequencers Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 73. Thermo Fisher Scientific Targeted Gene Sequencers Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. Illumina Company Information
 Table 76. Illumina Description and Business Overview
 Table 77. Illumina Targeted Gene Sequencers Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 78. Illumina Targeted Gene Sequencers Product
 Table 79. Illumina Recent Developments/Updates
 Table 80. Pacific Biosciences Company Information
 Table 81. Pacific Biosciences Description and Business Overview
 Table 82. Pacific Biosciences Targeted Gene Sequencers Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 83. Pacific Biosciences Targeted Gene Sequencers Product
 Table 84. Pacific Biosciences Recent Developments/Updates
 Table 85. Oxford Nanopore Technologies Company Information
 Table 86. Oxford Nanopore Technologies Description and Business Overview
 Table 87. Oxford Nanopore Technologies Targeted Gene Sequencers Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 88. Oxford Nanopore Technologies Targeted Gene Sequencers Product
 Table 89. Oxford Nanopore Technologies Recent Developments/Updates
 Table 90. Element Biosciences Company Information
 Table 91. Element Biosciences Description and Business Overview
 Table 92. Element Biosciences Targeted Gene Sequencers Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 93. Element Biosciences Targeted Gene Sequencers Product
 Table 94. Element Biosciences Recent Developments/Updates
 Table 95. Roche Company Information
 Table 96. Roche Description and Business Overview
 Table 97. Roche Targeted Gene Sequencers Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 98. Roche Targeted Gene Sequencers Product
 Table 99. Roche Recent Developments/Updates
 Table 100. Mgi Tech Company Information
 Table 101. Mgi Tech Description and Business Overview
 Table 102. Mgi Tech Targeted Gene Sequencers Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 103. Mgi Tech Targeted Gene Sequencers Product
 Table 104. Mgi Tech Recent Developments/Updates
 Table 105. GeneMind Company Information
 Table 106. GeneMind Description and Business Overview
 Table 107. GeneMind Targeted Gene Sequencers Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 108. GeneMind Targeted Gene Sequencers Product
 Table 109. GeneMind Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Targeted Gene Sequencers Distributors List
 Table 113. Targeted Gene Sequencers Customers List
 Table 114. Targeted Gene Sequencers Market Trends
 Table 115. Targeted Gene Sequencers Market Drivers
 Table 116. Targeted Gene Sequencers Market Challenges
 Table 117. Targeted Gene Sequencers Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Targeted Gene Sequencers
 Figure 2. Global Targeted Gene Sequencers Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Targeted Gene Sequencers Market Share by Type: 2025 & 2032
 Figure 4. Single Carrier Product Picture
 Figure 5. Multi-Carrier Product Picture
 Figure 6. Global Targeted Gene Sequencers Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Targeted Gene Sequencers Market Share by Application: 2025 & 2032
 Figure 8. Scientific Research
 Figure 9. Clinical Medicine
 Figure 10. Agriculture
 Figure 11. Others
 Figure 12. Global Targeted Gene Sequencers Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Targeted Gene Sequencers Market Size (US$ Million), 2021–2032
 Figure 14. Global Targeted Gene Sequencers Sales (Units), 2021–2032
 Figure 15. Global Targeted Gene Sequencers Average Price (K US$/Unit), 2021–2032
 Figure 16. Targeted Gene Sequencers Report Years Considered
 Figure 17. Targeted Gene Sequencers Sales Share by Manufacturers in 2025
 Figure 18. Global Targeted Gene Sequencers Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Targeted Gene Sequencers Players: Market Share by Revenue in Targeted Gene Sequencers in 2025
 Figure 20. Targeted Gene Sequencers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Targeted Gene Sequencers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Targeted Gene Sequencers Sales Market Share by Country (2021–2032)
 Figure 23. North America Targeted Gene Sequencers Revenue Market Share by Country (2021–2032)
 Figure 24. United States Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Targeted Gene Sequencers Sales Market Share by Country (2021–2032)
 Figure 27. Europe Targeted Gene Sequencers Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Targeted Gene Sequencers Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Targeted Gene Sequencers Revenue Market Share by Region (2021–2032)
 Figure 35. China Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Targeted Gene Sequencers Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Targeted Gene Sequencers Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Targeted Gene Sequencers Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Targeted Gene Sequencers Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Targeted Gene Sequencers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Targeted Gene Sequencers by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Targeted Gene Sequencers by Type (2021–2032)
 Figure 55. Global Targeted Gene Sequencers Price (K US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Targeted Gene Sequencers by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Targeted Gene Sequencers by Application (2021–2032)
 Figure 58. Global Targeted Gene Sequencers Price (K US$/Unit) by Application (2021–2032)
 Figure 59. Targeted Gene Sequencers Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona